Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,371 | -32,758 | -23,235 | -15,857 | -8,473 |
| Depreciation Amortization | 158 | 274 | 102 | 21 | 10 |
| Accounts payable and accrued liabilities | -1,215 | 417 | -341 | 1,561 | 594 |
| Other Working Capital | -89 | 1,058 | 1,150 | 1,408 | 3,060 |
| Other Operating Activity | 1,939 | 2,009 | 2,248 | -242 | 136 |
| Operating Cash Flow | $-7,578 | $-29,000 | $-20,076 | $-13,109 | $-4,673 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -32 | -27 | -12 | N/A |
| Investing Cash Flow | $N/A | $-32 | $-27 | $-12 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 14,000 | 14,000 | N/A | N/A |
| Common Stock Issued | N/A | 46 | 37 | 30 | N/A |
| Other Financing Activity | 4,147 | 2,674 | 2,046 | -42 | 0 |
| Financing Cash Flow | $4,147 | $16,720 | $16,083 | $-12 | $N/A |
| Beginning Cash Position | 45,001 | 57,313 | 57,313 | 57,313 | 57,313 |
| End Cash Position | 41,570 | 45,001 | 53,293 | 44,180 | 52,640 |
| Net Cash Flow | $-3,431 | $-12,312 | $-4,020 | $-13,133 | $-4,673 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,578 | -29,000 | -20,076 | -13,109 | -4,673 |
| Capital Expenditure | N/A | -32 | -27 | -12 | N/A |
| Free Cash Flow | -7,578 | -29,032 | -20,103 | -13,121 | -4,673 |